A. Wheatley

发表

Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction

D. Postma, I. Hall, H. Stefánsson, 2009, Nature Genetics.

The glutamine 27 beta2-adrenoceptor polymorphism is associated with elevated IgE levels in asthmatic families.

I. Hall, N. Morton, A. Wheatley, 1997, The Journal of allergy and clinical immunology.

Contribution of ADAM33 polymorphisms to the population risk of asthma

I. Hall, K. Stefánsson, H. Hakonarson, 2005, Thorax.

5-Lipoxygenase polymorphism and in-vivo response to leukotriene receptor antagonists

I. Hall, A. Wheatley, B. Lipworth, 2002, European Journal of Clinical Pharmacology.

Association of Glu 27 β2-adrenoceptor polymorphism with lower airway reactivity in asthmatic subjects

I. Hall, A. Wheatley, S. Liggett, 1995, The Lancet.

Possible role of the 4G/5G polymorphism of the plasminogen activator inhibitor 1 gene in the development of asthma.

I. Hall, A. Wheatley, J. D. Del Mundo, 2001, The Journal of allergy and clinical immunology.

β2 adrenoceptor promoter polymorphisms: extended haplotypes and functional effects in peripheral blood mononuclear cells

D. Postma, I. Hall, G. Koppelman, 2002, Thorax.

Association of CCR5 ▵32 with reduced risk of asthma

R. Hubbard, I. Hall, A. Wheatley, 1999, The Lancet.

Association of CCR5 delta32 with reduced risk of asthma.

R. Hubbard, I. Hall, A. Wheatley, 1999, Lancet.

Identification of novel polymorphisms within the promoter region of the human β2 adrenergic receptor gene

I. Hall, A. Wheatley, M. Scott, 1999, British journal of pharmacology.

Association of glutamine 27 polymorphism of β2 adrenoceptor with reported childhood asthma: population based study

I. Hall, A. Wheatley, P. Helms, 1998, BMJ.

Association of the Gln 27 beta 2-adrenoceptor polymorphism and IgE variability in asthmatic families.

I. Hall, N. Morton, A. Wheatley, 1997, Chest.

Beta2-adrenoceptor polymorphism and bronchoprotective sensitivity with regular short- and long-acting beta2-agonist therapy.

I. Hall, A. Wheatley, B. Lipworth, 1999, Clinical science.

Methods for Determining β(2)-Adrenoreceptor Genotype.

I. Hall, A. Wheatley, J. Dewar, 2000 .

Fc(epsilon)RI-(beta) polymorphisms unlikely to contribute substantially to genetic risk of allergic disease

I. Hall, A. Wheatley, J. Dewar, 1996, BMJ.

&bgr;2-Adrenoceptor Polymorphism Determines Vascular Reactivity in Humans

A. Wheatley, J. Cockcroft, J. P. Noon, 2000, Hypertension.

β2-Adrenoceptor polymorphism and bronchoprotective sensitivity with regular short- and long-acting β2-agonist therapy

I. Hall, A. Wheatley, B. Lipworth, 1999 .

β2-adrenoceptor polymorphisms and asthma from childhood to middle age in the British 1958 birth cohort: a genetic association study

I. Sayers, D. Strachan, I. Hall, 2006, The Lancet.

Identification of the autoantigen SART-1 as a candidate gene for the development of atopy.

I. Hall, A. Wheatley, J. Hewitt, 2002, Human molecular genetics.

Association analysis of β2 adrenoceptor polymorphisms with hypertension in a Black African population

N. Samani, A. Wheatley, J. Cockcroft, 2000, Journal of hypertension.

Genetic variation at the growth hormone (GH1) and growth hormone receptor (GHR) loci as a risk factor for hypertension and stroke

Yasmin, I. Hall, A. Wheatley, 2006, Human Genetics.

Association of beta‐2‐adrenoceptor polymorphisms and pulmonary function in patients with chronic obstructive pulmonary disease

A. Wheatley, S. Parker, A. Wardlaw, 2006 .

Rapid Biodiversity Assessment of the Vava'u Archipelago, Kingdom of Tonga

A. Wheatley, J. Atherton, S. Mckenna, 2014 .

β2-adrenoceptor polymorphisms and asthma from childhood to middle age in the British 1958 birth cohort: a genetic association study

I. Sayers, D. Strachan, I. Hall, 2006, The Lancet.

Beta2-adrenoceptor polymorphisms and asthma from childhood to middle age in the British 1958 birth cohort: a genetic association study.

W. McArdle, A. Wheatley, Khalid A Al Balushi, 2006, Lancet.